S'abonner

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series - 27/08/20

Doi : 10.1016/S1473-3099(20)30364-9 
Ivan Fan-Ngai Hung, ProfMD a, b, , Vincent Chi-Chung Cheng, MD c, d, , Xin Li, MRCP c, Anthony Raymond Tam, MRCP a, Derek Ling-Lung Hung, FRCPath c, Kelvin Hei-Yeung Chiu, MRCP c, Cyril Chik-Yan Yip, PhD c, Jian-Piao Cai, BSc b, Deborah Tip-Yin Ho, MSc b, Shuk-Ching Wong, MNurs c, d, Sally Sau-Man Leung, BSc c, Man-Yee Chu, MRCP f, Milky Oi-Yan Tang, MSc a, Jonathan Hon-Kwan Chen, PhD c, Rosana Wing-Shan Poon, PhD c, Agnes Yim-Fong Fung, BSc b, Ricky Ruiqi Zhang, MSc a, b, Erica Yuen-Wing Yan, MNurs b, Lin-Lei Chen, BSc b, Charlotte Yee-Ki Choi, BSc b, Kit-Hang Leung, BSc c, Tom Wai-Hin Chung, MRCP c, Sonia Hiu-Yin Lam, FRCR e, Tina Poy-Wing Lam, FRCR e, Jasper Fuk-Woo Chan, MD b, c, Kwok-Hung Chan, PhD b, Tak-Chiu Wu, FRCP f, Pak-Leung Ho, MD b, c, Johnny Wai-Man Chan, FRCP f, Chak-Sing Lau, ProfMD a, Kelvin Kai-Wang To, MD b, c, Kwok-Yung Yuen, ProfMD b, c,
a Infectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China 
b State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China 
c Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China 
d Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China 
e Department of Radiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China 
f Department of Medicine, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China 

* Correspondence to: Prof Kwok-Yung Yuen, State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China State Key Laboratory of Emerging Infectious Diseases Carol Yu Centre for Infection University of Hong Kong Hong Kong Special Administrative Region China

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Summary

Background

A cruise ship is a closed-off environment that simulates the basic functioning of a city in terms of living conditions and interpersonal interactions. Thus, the Diamond Princess cruise ship, which was quarantined because of an onboard outbreak of COVID-19 in February, 2020, provides an opportunity to define the shedding pattern of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient antibody responses before and after the onset of symptoms.

Methods

We recruited adult (≥18 years) passengers from Hong Kong who had been on board the Diamond Princess cruise ship docked in Yokohama, Japan in February, 2020. All participants had been found to be negative for SARS-CoV-2 by RT-PCR 4 days before disembarking and were transferred to further quarantine in a public estate in Hong Kong, where they were recruited. Participants were prospectively screened by quantitative RT-PCR (RT-qPCR) of nasopharyngeal and throat swabs, and serum IgG and IgM against internal nucleoprotein and the surface spike receptor-binding protein (RBD) of SARS-CoV-2 at baseline (upon entering quarantine) and on days 4, 8, and 12 of quarantine.

Findings

On Feb 22, 2020, 215 adults were recruited, of whom nine (4%; 95% CI 2–8) were positive for SARS-CoV-2 by RT-qPCR or serology and were hospitalised. Of these nine patients, nasopharyngeal swab RT-qPCR was positive in eight patients (89%; 57–99) at baseline. All nine patients were positive for anti-RBD IgG by day 8. Eight (89%; 57–99) were simultaneously positive for nasopharyngeal swab RT-PCR and anti-RBD IgG. One patient who was positive for anti-RBD IgG and had a negative viral load had multifocal peripheral ground-glass changes on high-resolution CT that were typical of COVID-19. Five patients (56%; 27–81) with ground-glass changes on high-resolution CT were found to have higher anti-nucleoprotein-IgG OD values on day 8 and 12 and anti-RBD IgG OD value on day 12 than patients without ground-glass changes. Six (67%; 35–88) patients remained asymptomatic throughout the 14-day quarantine period.

Interpretation

Patients with COVID-19 can develop asymptomatic lung infection with viral shedding and those with evidence of pneumonia on imaging tend to have an increased antibody response. Positive IgG or IgM confirmed infection of COVID-19 in both symptomatic and asymptomatic patients. A combination of RT-PCR and serology should be implemented for case finding and contact tracing to facilitate early diagnosis, prompt isolation, and treatment.

Funding

Shaw Foundation Hong Kong; Sanming-Project of Medicine (Shenzhen); High Level-Hospital Program (Guangdong Health Commission).

Le texte complet de cet article est disponible en PDF.

Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 20 - N° 9

P. 1051-1060 - septembre 2020 Retour au numéro
Article précédent Article précédent
  • Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
  • Sakiko Tabata, Kazuo Imai, Shuichi Kawano, Mayu Ikeda, Tatsuya Kodama, Kazuyasu Miyoshi, Hirofumi Obinata, Satoshi Mimura, Tsutomu Kodera, Manabu Kitagaki, Michiya Sato, Satoshi Suzuki, Toshimitsu Ito, Yasuhide Uwabe, Kaku Tamura
| Article suivant Article suivant
  • Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
  • Kathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, Andrew Hale, Jessica L Ansel, Diane G Kanjilal, Kate Jaegle, Lauren Peter, Erica N Borducchi, Joseph P Nkolola, Tatenda Makoni, Rachel Fogel, Connor Bradshaw, Anna Tyler, Edward Moseley, Abishek Chandrashekar, Katherine E Yanosick, Michael S Seaman, Kenneth H Eckels, Rafael A De La Barrera, Jason Thompson, Peter Dawson, Stephen J Thomas, Nelson L Michael, Kayvon Modjarrad, Dan H Barouch

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.